Safety and efficacy of plerixafor dose escalation for the mobilization of CD34
+
hematopoietic progenitor cells in patients with sickle cell disease: interim results
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34
+
hematopoietic progenitor cells in patients with sickle cell disease: interim results
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started